Dr. Forbess is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8631 W 3rd St
Suite 700 East
Los Angeles, CA 90048Phone+1 310-854-3539Fax+1 310-652-3914
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2009 - 2011
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2007 - 2009
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 2006 - 2007
- Northwestern University The Feinberg School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2012 - 2025
- NY State Medical License 2008 - 2013
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Amazing Charts EHR, AmazingCharts, LLC, 2012-2013
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 122 citationsA large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.F. David Carmona, Sarah L. Mackie, Jose Ezequiel Martin, John C. Taylor, Augusto Vaglio
American Journal of Human Genetics. 2015-04-02 - 33 citationsRituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled t...Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale
Annals of the Rheumatic Diseases. 2023-07-01 - 89 citationsRituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale
Annals of the Rheumatic Diseases. 2020-09-01
Authored Content
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: